Aminoglycosides: a practical review

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Aminoglycosides are bactericidal antibiotics targeting aerobic Gram-negative bacteria.
• They exhibit synergistic activity with certain Gram-positive organisms.
• Gentamicin and amikacin are key agents, with amikacin showing efficacy against resistant strains.

Purpose of the Study:

• To review the clinical applications and dosing strategies of aminoglycoside antibiotics.
• To evaluate the safety, efficacy, and cost-effectiveness of single daily dosing versus traditional multiple dosing.
• To discuss strategies for mitigating aminoglycoside toxicity.

Main Methods:

• Literature review of clinical studies and guidelines on aminoglycoside use.
• Analysis of pharmacokinetic and pharmacodynamic properties influencing dosing.
• Examination of data on treatment outcomes and adverse events.

Main Results:

• Aminoglycosides are crucial for severe abdominal, urinary tract, bacteremic, and endocarditis infections.
• Single daily dosing is feasible due to concentration-dependent killing and post-antibiotic effect, showing potential for reduced toxicity.
• This dosing strategy is safe, effective, and cost-efficient, though traditional dosing is preferred for endocarditis and pediatric patients.

Conclusions:

• Single daily aminoglycoside dosing is a viable and advantageous strategy in many clinical scenarios.
• Careful patient selection and monitoring are essential to minimize nephrotoxicity and ototoxicity.
• Optimized dosing regimens enhance therapeutic outcomes while managing resistance and toxicity risks.